Bio-Rad Labs (BIO) Tops Q2 EPS by 32c
Tweet
Share
E-mail
Get Alerts BIO Hot Sheet
Price: $282.44 -0.78%
Revenue Growth %: -4.3%
Financial Fact:
Other (income) expense, net: -11.21M
Today's EPS Names:
DTGI, CRMT, MAYS, More
Revenue Growth %: -4.3%
Financial Fact:
Other (income) expense, net: -11.21M
Today's EPS Names:
DTGI, CRMT, MAYS, More
Join SI Premium – FREE
Bio-Rad Labs (NYSE: BIO) reported Q2 EPS of $3.00, $0.32 better than the analyst estimate of $2.68. Revenue for the quarter came in at $681.1 million versus the consensus estimate of $697.96 million.
For earnings history and earnings-related data on Bio-Rad Labs (BIO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- SanDisk and Micron surge as Apple confirms memory price pass-through
- Pfizer reaffirms 2026 guidance after CFO transition news
- JPMorgan Upgrades Sika AG (SIKA:SW) (SKFOF) to Neutral
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
